UPDATE: Because we get a ton of emails from Stansberry victims, we’re offering everyone special pricing to show you not everyone in the stock picking business is evil. If you’ve been abused emotionally and financially, pleaseand we’ll tell you all about how we can help!
See my 2010 performance and learn the difference between me and people like this guy below
With fat pill maker Arena Pharmaceuticals, Inc. (ARNA) getting rejected by the FDA over the weekend and currently trading int he mid $1/share range, I thought this would be a good time to highlight two verrrry different takes on the stock before this final determination was handed down.
First a guest post from a “The Fat Pill Stock With Slim Odds Of Success?” which when the stock was trading at $7/share argued the price was ripe for a fall.subscriber entitled
“This is the kind of situation that can change your life… where a
$10,000 stake can allow you to literally quit work, forever.”
- Porter Stansberry, Founder, S&A Research
…with ARNA trading for less than half of what it was when Porter said that, a $10,000 stake did not allow his subscribers to quit work, inf act they had to work more to make up for the $5,000+ loss…welcome to the world of slimy marketing and why it’s SO dangerous for newbie investors…Porter and his rumored $30-million-a-year-newsletter-company are pure EVIL.
See Porter Stansberry’s reviews and read his “research” piece below that turned out to be dead wrong and begin to understand how corrupt he is and why I think Porter Stansberry is the real life Hyman Roth.
We’ve waited 2 years for this day.
On March 30th, there’ll be an announcement of FDA results for a new drug that could create the single biggest return of any investment we’ve ever found, in 10 years.
“All eyes are on the data,” says Business Week. “It could be a multi-billion dollar drug, and so far, all the numbers have been positive.” BioWorld writes: “It could be the largest pharmaceutical market ever.”
When you see (below) what the drug treats… I think you’ll see why S&A has now spent over $200,000 since 2006, uncovering the full details.
“It’s the perfect storm,” writes drug expert Jack Windin. “A totally new chemical entity with virtually no competition.”
So far – the drug has successfully cleared both Phase 1 and 2 FDA clinical trials… and is just weeks from the announcement of Phase 3 results… the last trial before it could launch on a scale potentially unseen since the release of penicillin.
As Forbes reports: People across America are already writing letters to the small company who owns the patent… asking: “How can I get your drug?”
But the big question, of course, is: “Will the drug be approved by the FDA?”
By March 30 – we’ll hear the official announcement of test results. It’s a decision we’ve been following daily since trials first began more than 2 years ago.
And while most people have no idea what will happen… we’ve been able to access early results directly from the company, and they’re even better than we hoped.
In short: as of Dec. 15, 2008, early clinical results suggest the drug is safe… has a near-perfect success rate… has a 500% efficiency… and finally, get this: will target 45% of the U.S. population – almost 1 out of 2 Americans.
As one FDA expert puts it: “If results on March 30th turn out even half as good as we expect… this could be the best-selling drug in the history of medicine.”
Best of all: All the rights to the drug belong to a single company, a penny stock. At today’s prices… a 4-point jump alone would double your money.
In other words: if the results are positive for this new drug on March 30th as we expect… a single stake in this company could make you a fortune, overnight. We estimate as much as $195,600… but only if you get in right now (you’ll see why below).
Again, we’ve waited 2 years for this day. It’s the kind of situation we built our firm on back in 1999… investments that can literally change your life.
Let me give you the full story…
Years from now – and perhaps for the rest of their lives – a small group of people will remember exactly what they were doing on March 30, 2009.
You see, by that morning, there will be an announcement that’s unlike just about any other FDA-related release. It’s the single announcement that allows regular investors like you and me the rare chance to make a small fortune…
When Celgene (CELG) heard a similar announcement in 1998, for example, the stock returned 1,002%… turning every $5,000 into $50,100 profit. (We’re expecting an even bigger return this March.)
The same thing happened in 1991 to Amgen (AMGN) – which immediately doubled… and went on to gain an unbelievable 1,700%.
In short – by March 30th… we’re expecting an announcement of something more than just new drug approval…
Quite simply, we expect approval for a new drug unlike anything to ever go public in the 81-year history of modern biotech. It’s a drug that simply hasn’t existed, in any useable form… until the company I’m telling you about invented it.
And yet it offers the one cure that almost everybody wishes for – at some point in life. (Don’t worry, I’m not talking about something farfetched, like a cancer cure… or a fountain of youth.)
These results could launch “the bestselling drug in the history of medicine.”
In fact, chances are you know someone who could benefit from the drug, and will even prescribe to it… after test results come out by March 30th.
The drug could help so many people a neuroscience writer in Dallas went as far as to say recently, “The FDA should lower requirements and speed up approval.”
It’s been described by even conservative health writers with words like: “runaway bestseller”… “blockbuster potential”… and “sell like gangbusters.” Forbes wrote of the “magic pill,” and went on to say:
“If approved, it could be a billion-dollar drug.”